关注
Urmi Bajpai
Urmi Bajpai
Professor, Department of Biomedical Science Acharya Narendra Dev College, University of
在 andc.du.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Clinical significance of 14-3-3 zeta in human esophageal cancer
U Bajpai, R Sharma, T Kausar, S Dattagupta, TK Chattopadhayay, ...
The International journal of biological markers 23 (4), 231-237, 2008
412008
Isolation and characterization of bacteriophages from India, with lytic activity against Mycobacterium tuberculosis
U Bajpai, AK Mehta, K Eniyan, A Sinha, A Ray, S Virdi, S Ahmad, A Shah, ...
Canadian journal of microbiology 64 (7), 483-491, 2018
372018
Crystal structure of UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis
K Eniyan, S Dharavath, R Vijayan, U Bajpai, S Gourinath
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1866 (3), 397-406, 2018
352018
Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis
J Rani, Y Silla, K Borah, S Ramachandran, U Bajpai
Journal of Biomolecular Structure and Dynamics 38 (9), 2521-2532, 2020
312020
Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis
K Eniyan, A Kumar, GV Rayasam, A Perdih, U Bajpai
Scientific reports 6 (1), 35134, 2016
302016
Active versus passive case finding for tuberculosis in marginalised and vulnerable populations in India: comparison of treatment outcomes
HD Shewade, V Gupta, S Satyanarayana, S Kumar, P Pandey, UN Bajpai, ...
Global health action 12 (1), 1656451, 2019
232019
Characterization and genome analysis of B1 sub-cluster mycobacteriophage PDRPxv
A Sinha, K Eniyan, P Manohar, N Ramesh, U Bajpai
Virus research 279, 197884, 2020
222020
Mineralization of [14C]octadecane by Acinetobacter calcoaceticus S19
U Bajpai, RC Kuhad, S Khanna
Canadian journal of microbiology 44 (7), 681-686, 1998
161998
Alternative treatment strategies for secondary bacterial and fungal infections associated with COVID-19
R Das, K Kotra, P Singh, B Loh, S Leptihn, U Bajpai
Infectious diseases and therapy, 1-25, 2022
152022
Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in Mycobacterium tuberculosis
K Eniyan, J Rani, S Ramachandran, R Bhat, IA Khan, U Bajpai
SLAS DISCOVERY: Advancing Life Sciences R&D 25 (1), 70-78, 2020
142020
Structure based virtual screening to identify inhibitors against MurE Enzyme of Mycobacterium tuberculosis using AutoDock Vina
S Singh, U Bajpai, AM Lynn
Bioinformation 10 (11), 697, 2014
132014
Design and Synthesis of Various 5′-Deoxy-5′-(4-Substituted-1,2,3-Triazol-1-yl)-Uridine Analogues as Inhibitors of Mycobacterium tuberculosis Mur Ligases
V Hervin, R Arora, J Rani, S Ramchandran, U Bajpai, LA Agrofoglio, ...
Molecules 25 (21), 4953, 2020
122020
In silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2
J Rani, A Bhargav, FI Khan, S Ramachandran, D Lai, U Bajpai
Journal of Biomolecular Structure and Dynamics 40 (22), 12118-12134, 2022
102022
Functional characterization of the endolysins derived from mycobacteriophage PDRPxv
K Eniyan, A Sinha, S Ahmad, U Bajpai
World Journal of Microbiology and Biotechnology 36, 1-11, 2020
102020
Data collection using open access technology in multicentre operational research involving patient interviews
HD Shewade, SS Chadha, V Gupta, JP Tripathy, S Satyanarayana, ...
Public health action 7 (1), 74-77, 2017
102017
Screening of compound library identifies novel inhibitors against the MurA enzyme of Escherichia coli
D Raina, H Tiwari, S Sharma, Deepika, PK Chinthakindi, A Nargotra, ...
Applied Microbiology and Biotechnology 105, 3611-3623, 2021
82021
Functional characterization of a DNA-dependent AAA ATPase in a F-cluster mycobacteriophage
R Das, U Bajpai
Virus Research 323, 198957, 2023
62023
Functional analysis of TPM domain containing Rv2345 of Mycobacterium tuberculosis identifies its phosphatase activity
A Sinha, K Eniyan, S Sinha, AM Lynn, U Bajpai
Protein expression and purification 111, 23-27, 2015
62015
Are we missing ‘previously treated’smear-positive pulmonary tuberculosis under programme settings in India? A cross-sectional study
HD Shewade, V Gupta, S Satyanarayana, A Kharate, L Murali, ...
F1000Research 8, 2019
52019
Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens
S Shah, R Das, B Chavan, U Bajpai, S Hanif, S Ahmed
Frontiers in Microbiology 14, 1170418, 2023
42023
系统目前无法执行此操作,请稍后再试。
文章 1–20